TY  - GEN
AU  - Garcia-Pavia, Pablo
AU  - Bilen, Ozlem
AU  - Burroughs, Melissa
AU  - Costabel, Juan Pablo
AU  - de Barros Correia, Edileide
AU  - Dybro, Anne M
AU  - Elliott, Perry
AU  - Lakdawala, Neal K
AU  - Mann, Amy
AU  - Nair, Ajith
AU  - Nassif, Michael E
AU  - Poulsen, Steen H
AU  - Reant, Patricia
AU  - Schulze, P Christian
AU  - Wang, Andrew
AU  - Berhane, Indrias
AU  - Heitner, Stephen B
AU  - Jacoby, Daniel L
AU  - Kupfer, Stuart
AU  - Malik, Fady I
AU  - Meng, Lisa
AU  - Sohn, Regina
AU  - Wohltman, Amy
AU  - Fifer, Michael A
PY  - 2025
UR  - https://hdl.handle.net/20.500.12105/26806
AB  - Beta-blockers and nondihydropyridine calcium-channel blockers have been standard-of-care (SOC) medications for patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), even though these agents do not directly affect the underlying...
LA  - eng
PB  - Elsevier
KW  - aficamten
KW  - beta-blocker
KW  - gradient
KW  - hypertrophic cardiomyopathy
KW  - obstructive
TI  - Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics.
TY  - research article
ER  -